SeaStar Medical Holding (ICU) Accounts Payables (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Accounts Payables came in at $719000.0 in Q1 2026, down 78.83% YoY from $3.4 million in Q1 2025, and down 24.16% on a QoQ basis from $948000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Accounts Payables (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Accounts Payables data on file, last reported at $719000.0 in Q1 2026.
- Quarterly Accounts Payables fell 78.83% year-over-year to $719000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $719000.0 (down 78.83% YoY) and the FY2025 annual result came in at $948000.0, down 68.88% from the prior year.
- Accounts Payables declined to $719000.0 in Q1 2026, from $948000.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $5.0 million in Q3 2023 to a low of $719000.0 in Q1 2026.
- A 5-year average of $3.0 million and a median of $3.2 million in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 2167.06% — and 2026, when it plunged 78.83%.
- Tracing ICU's Accounts Payables over 5 years: stood at $1.9 million in 2022, then surged by 126.88% to $4.4 million in 2023, then plunged by 30.33% to $3.0 million in 2024, then tumbled by 68.88% to $948000.0 in 2025, then fell by 24.16% to $719000.0 in 2026.
- The last three Accounts Payables figures came in at $719000.0 (Q1 2026), $948000.0 (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 750,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 750,000.00 |
| Mar 31, 2026 | 719,000.00 |
| Dec 31, 2025 | 948,000.00 |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 4.36 Mn |
| Mar 31, 2023 | 3.02 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Dec 31, 2021 | 85,000.00 |
| Dec 31, 2020 | 123,031.00 |